Fierce Healthcare July 23, 2024
Noah Tong

Lawmakers bashed the business practices of pharmacy benefit managers during a House Committee on Oversight and Accountability hearing Tuesday.

When they were asked repeatedly about steering patients, increased drug prices and pharmacy closures, the company executives largely refuted claims thrown at them.

Lawmakers were overwhelmingly frustrated with the perceived non-answers given and at one point reminded the leaders of Optum Rx, Express Scripts and CVS Caremark they were under oath. Witnesses at times were united in silence after lawmakers asked questions, knowing they would not provide an answer that would satisfy the members.

The hearing coincided with the release of a new report (PDF) compiled by the committee that found the three largest PBMs — which are vertically integrated with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
First Comprehensive Review of SMA Drugs Offers Long-Term Insights, Outcome Gaps
Drugmaker might be 1st healthcare company to top $1 trillion valuation
Prescription drug spending grew even after rebates
Remote monitoring and pharmacist helps improve hard-to-control blood pressure, research shows
Pharma Pulse 9/5/24: Legal Advice for DSCSA Compliance Teams, Pharmacy Students Discuss Learning Through Social Media Platforms & more

Share This Article